Martina
Martina Andgerg-Blomster, Fin-Kirkkonummi FI
Patent application number | Description | Published |
---|---|---|
20090221039 | FUSION PROTEINS BETWEEN PLANT CELL-WALL DEGRADING ENZYMES AND A SWOLLENIN, AND THEIR USES - The invention relates to fusion proteins including at least a swollenin and at least a plant cell-wall degrading enzyme, the swollenin, and plant cell-wall degrading enzyme, being recombinant proteins corresponding to native proteins in fungi, or mutated forms thereof. The invention also relates to the use of fusion proteins as defined above, for carrying out processes of plant cell-wall degradation in the frame of the preparation, from plants or vegetal by-products, of compounds of interest located in plant cell-wall, or in the frame of the bleaching of pulp and paper, or for biofuel production, or food industries. | 09-03-2009 |
Martina Bachfischer, Riedlhuette DE
Patent application number | Description | Published |
---|---|---|
20120248026 | Filter Element, Filter Device and Method for Producing a Filter Element - A filter element ( | 10-04-2012 |
20140305088 | Filter Element, Filter Device and Method for Producing a Filter Element - A filter element ( | 10-16-2014 |
Martina Balser, Pulheim DE
Patent application number | Description | Published |
---|---|---|
20100125109 | Use of Nanoporous Polymer Foams as Filter Materials - By reaction of one or more epoxy resins with an amphiphilic epoxy resin hardener in water in a phase inversion polymerization, nanoporous polymer foams are obtained. These foams are suitable as filter materials. | 05-20-2010 |
20100127204 | Use of Nanoporous Polymer Foams as Thermal Insulation Materials - By reaction of one or more epoxy resins with an amphiphilic epoxy resin hardener in water in a phase inversion polymerization, nanoporous polymer foams are obtained. These foams are suitable as thermal insulation materials. | 05-27-2010 |
Martina Barison, Masera Di Padova IT
Patent application number | Description | Published |
---|---|---|
20110034099 | POLYMERS, SUPPORT COMPRISING SAID POLYMERS AND USES THEREOF AS DYES CAPTURING AND BACTERICIDAL AGENTS - New polymers of formula (I) useful for capturing dyes dispersed in an aqueous environment for washing dyed textile articles, fibre-based support impregnated with the polymers of formula (I) and/or copolymers containing said polymers, related use of such polymer compounds and such support during a step for washing dyed textile articles, and process for producing such support. | 02-10-2011 |
Martina Becker, Lorrach DE
Patent application number | Description | Published |
---|---|---|
20080261897 | Formulation Containing a Polyphenol-Containing Composition and Isomaltulose - The present invention relates to formulations containing isomaltulose and a polyphenol-containing composition, uses of same and the use of isomaltulose for masking unwanted taste components, in particular bitter substances, in formulations, in particular in formulations containing tea extracts. | 10-23-2008 |
20130224349 | FORMULATION CONTAINING A POLYPHENOL-CONTAINING COMPOSITION AND ISOMALTULOSE - The present invention relates to formulations containing isomaltulose and a polyphenol-containing composition, uses of same and the use of isomaltulose for masking unwanted taste components, in particular bitter substances, in formulations, in particular in formulations containing tea extracts. | 08-29-2013 |
Martina Beishuizen, Rotterdam NL
Patent application number | Description | Published |
---|---|---|
20090004693 | Production of Polypeptides by Improved Secretion - The present invention relates to polypeptides that have an activity corresponding to at least one activity of the SEC61 polypeptide, polynucleotides encoding these polypeptides and the use thereof in the preparation of host cells suitable for production of a polypeptide of interest. Such host cells may have an increased capacity to secrete a polypeptide of interest. | 01-01-2009 |
20130144034 | METHOD FOR THE PRODUCTION OF A COMPOUND OF INTEREST - The present invention relates to a method for the production of a compound of interest by microbial fermentation, wherein the microbial host cell used has been modified in its genome such that it results in a deficiency in the production of at least one non-ribosomal peptide synthase. The present invention further relates to a microbial host cell that has been modified in its genome such that it results in a deficiency in the production of at least one non-ribosomal peptide synthase. The invention further relates to a compound of interest. | 06-06-2013 |
Martina Beissinger, Regensburg DE
Patent application number | Description | Published |
---|---|---|
20100092968 | Method and Means for Enrichment, Removal and Detection of Gram-Positive Bacteria - The present invention relates to polypeptides comprising a enzymatically non-active cell wall binding domain of an endolysin or another cell wall lysing enzyme, and a sequence according to SEQ ID NO: 1 or derivatives thereof, wherein the polypeptide besides the cell wall binding domain comprises no further domains of an endolysin, as well as means for their preparation. The present invention further relates to methods for binding, enriching, removing from a sample, capturing and/or detecting bacteria, particularly gram positive bacteria. | 04-15-2010 |
20110243916 | MODIFIED ENDOLYSIN PLY511 - The present invention relates to polypeptides with a changed amino acid sequence on at least one amino acid position compared to the amino acid sequence according to SEQ ID NO: 1. The present invention further relates to the nucleotide sequences encoding the polypeptide, vectors, comprising the nucleotide sequences and host cells for expression of the polypeptide. The present invention further relates to the use of the polypeptides as a human, veterinary medical or diagnostic substance, in food, in cosmetics, as disinfectant or in the environmental field. | 10-06-2011 |
Martina Bellanova, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20110207094 | METHOD FOR TRAINING SPEECH PERCEPTION AND TRAINING DEVICE - The speech perception of hearing-aid wearers and wearers of other hearing devices is intended to be improved. To this end, a method for training the speech perception of a person, who is wearing a hearing device, is provided, in which a first speech component is presented acoustically and the latter is identified by the person wearing the hearing device. Subsequently, there is automated modification of the acoustic presentation of the presented speech component and the aforementioned steps are repeated with the modified presentation until, if the identification is incorrect, a prescribed maximum number of repetitions has been reached. Otherwise, if the first speech component is identified correctly or if the number of incorrect identifications of the first speech component is one more than the maximum repetition number, a second speech component is presented acoustically. This allows a plurality of speech components to be trained in respectively a number of steps. | 08-25-2011 |
20130202124 | METHOD FOR TESTING HEARING AIDS - A method for testing hearing aids, particularly in respect of the effect thereof on speech comprehension, is improved. The method has the following steps: a) a test system is provided, b) an audible voice signal in the form of at least one meaningless syllable is selected and presented c) the meaningless syllable and a number of further meaningless syllables are displayed on a graphical user interface in the test system, d) a heard meaningless syllable is selected from the displayed meaningless syllables by the user, e) the selection made is evaluated, and f) method steps c) to e) are repeated until a termination criterion is encountered. The audible voice signal is selected in each case on the basis of at least one selection made by the person in response to a previously presented voice signal. The method allows particularly fast and informative hearing aid tests. | 08-08-2013 |
20130209970 | Method for Training Speech Recognition, and Training Device - Speech recognition is improved for wearers of hearing aids and other hearing devices by training the speech recognition. A first speech element is acoustically presented, and the element is identified by the person wearing the hearing device. Subsequently, the acoustic presentation of the presented speech element is automatically changed and the aforementioned steps are repeated (S | 08-15-2013 |
Martina Bronold, Wolfratshausen DE
Patent application number | Description | Published |
---|---|---|
20110143454 | METHOD FOR DETECTION OF SPECIFIC IMMUNOGLOBULIN CLASS G ANTIBODIES - The invention relates to a method for determining an analyte in a sample by means of an assay that can be carried out in a one-step format without performing washing steps. The method includes a first analyte-specific receptor that contains at least one bonding point for the analyte, e.g., several antibodies on a particle, as well as a second analyte-specific receptor that can selectively bond to an arrangement comprising at least two analyte molecules which are bound to the first receptor. An antibody sandwich immune assay is described in which the detection is based on electrochemiluminescence. | 06-16-2011 |
Martina Corasaniti, Caronno Pertusella (va) IT
Patent application number | Description | Published |
---|---|---|
20120202946 | Process for the isolation of sulfonyl fluoride polymers and polymers obtained therefrom - The invention relates to a process for the isolation of (per)fluorinated polymers containing sulfonyl fluoride functional groups from a polymerization latex. The process comprises adding the polymerization latex to an aqueous electrolyte solution under high shear stirring at a temperature equal to or lower than the glass transition temperature of the polymer. The invention further relates to the (per)fluorinated polymers containing sulfonyl fluoride functional groups isolated by the process and characterised by a loss of weight at 200° C. lower than 1% as determined by thermogravimetric analysis. | 08-09-2012 |
Martina Damayanti, Singapore SG
Patent application number | Description | Published |
---|---|---|
20110048957 | Method for forming an ultrathin Cu barrier/seed bilayer for integrated circuit device fabrication - A structure and method for forming a relatively thin diffusion barrier/seed bilayer for copper metallization in an electronic device is disclosed. A single layer of an alloy is formed over a dielectric (and possibly the copper layer). The alloy includes a copper platable metal (e.g., ruthenium) and a nitride forming material (e.g., tungsten) and nitrogen. The alloy layer is annealed, and the alloy naturally segregates into two layers. The first layer is a barrier layer including the nitride forming material and nitrogen. The second layer is a seed layer including the copper platable metal. | 03-03-2011 |
Martina Delbeck, Essen DE
Patent application number | Description | Published |
---|---|---|
20110245308 | SUBSTITUTED BENZYL AND PHENYLSULFONYL TRIAZOLONES, AND USE THEREOF - The present application relates to new, substituted benzyl-1,2,4-triazolones and phenylsulfonyl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 10-06-2011 |
20120004203 | TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD - The present invention relates to novel heterocyclically fused diaryldihydropyrimidine derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 01-05-2012 |
20120094968 | SULFONIC AMIDE AND SULFOXIMINE-SUBSTTTUTED DIARYL-DIHYDROPYRIMIDINONES AND USAGE THEREOF - The present application relates to novel sulfonamidw- or sulfoximine-substituted 1,4-diaryldihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 04-19-2012 |
20120208852 | Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof - The present application relates to new, heterocyclyl-substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 08-16-2012 |
20140038988 | TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD - The present invention relates to novel heterocyclically fused diaryldihydropyrimidine derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 02-06-2014 |
Martina Delbeck, Heilingenhaus DE
Patent application number | Description | Published |
---|---|---|
20110118221 | 1,4-DIARYL-PYRIMIDOPYRIDAZINE-2,5-DIONES AND THEIR USE - The present invention relates to novel 1,4-diarylpyrimido[4,5-d]pyridazine-2,5-dione derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 05-19-2011 |
Martina Delbeck, Heiligenhaus DE
Patent application number | Description | Published |
---|---|---|
20100261771 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF - The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 10-14-2010 |
20110034433 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES AND THEIR USE - The present invention relates to novel 4-(4-cyano-2-thioaryl)dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 02-10-2011 |
20110219462 | G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases - The present invention relates to use of the GPR30 gene for diagnosis and treatment of cardiovascular disorders, especially cardiomyopathy. The present invention also relates to a GPR30 deficient animal model, more specifically to a mouse in which the GPR30 gene is disrupted and which exhibits a cardiomyopathy, a tissue and a cell of the mouse and a process of producing the same. The present invention further relates to use of said knockout mouse as a model of cardiovascular diseases, especially cardiomyopathy, and a method of screening a compound useful for the prevention and/or treatment of cardiovascular diseases, especially cardiomyopathy, using the knockout mouse. | 09-08-2011 |
20120238607 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF - The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 09-20-2012 |
20130190330 | BISARYL-BONDED ARYLTRIAZOLONES AND USE THEREOF - The present application relates to novel bisaryl-linked 5-aryl-1,2,4-triazolone derivatives, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 07-25-2013 |
20130225646 | SUBSTITUTED N-PHENETHYLTRIAZOLONEACETAMIDES AND USE THEREOF - The present application relates to novel substituted N-phenethyltriazoloneacetamides, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 08-29-2013 |
20130231313 | SUBSTITUTED PHENYLACETATE AND PHENYLPROPANE AMIDES AND USE THEREOF - The present application relates to novel substituted phenylacetamides and phenylpropanamides, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders. | 09-05-2013 |
20140031391 | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use - The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders. | 01-30-2014 |
20140045802 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES AND THEIR USE - The present invention relates to novel 4-(4-cyano-2-thioaryl)dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 02-13-2014 |
20140155383 | USE OF CATHEPSIN K INHIBITION FOR THE TREATMENT AND/OR PROPHYLAXIS OF PULMONARY HYPERTENSION AND/OR HEART FAILURE - The present invention relates to the use of cathepsin K and/or cathepsin S inhibitors in a method for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure. | 06-05-2014 |
20150045344 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES AND USE THEREOF - The present invention relates to novel 4-(4-cyano-2-thioaryl)dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system. | 02-12-2015 |
Martina Doehlemann, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20110224535 | MAGNETIC RESONANCE-ASSISTED BIOPSY EXAMINATION METHOD, AND A MAGNETIC RESONANCE SYSTEM FOR IMPLEMENTING THE METHOD - In a magnetic resonance-assisted biopsy method for a biopsy examination, using magnetic resonance measurement executed by a magnetic resonance measurement unit and a biopsy unit and a computer console, the computer console is located separately from the magnetic resonance measurement unit, the following steps are implemented: | 09-15-2011 |
Martina Doleshal, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20090263803 | MIRNAS DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS - The present invention provides diagnostics and/or prognostic methods by identifying miRNAs that are differentially expressed or mis-regulated in various states of diseased, normal, cancerous, and/or abnormal tissues, including but not limited to cervix, skin, colon, breast, bladder, esophagus, liver, ovary, prostate, lung, pancreas, thyroid, kidney, stomach, testicle, uterus, spleen, tongue, brain, thymus, trachea and/or small intestine. In certain apsects, differential miRNA expression is initially determined by comparing miRNA expression between a normal tissue and cancer negative lymph node (LNneg), a normal tissue and a cancer positive lymph node (LNpos), a cancerous tissue and LNneg and/or LNpos, LNneg and LNpos. The methods of the invention are used to identify the presence or absence of non-lymphoid cells from other organs or tissues, and/or metastatic cancer cells present in lymph nodes. | 10-22-2009 |
20140141423 | miRNAs Differentially Expressed in Lymph Nodes from Cancer Patients - The present invention provides diagnostics and/or prognostic methods by identifying miRNAs that are differentially expressed or mis-regulated in various states of diseased, normal, cancerous, and/or abnormal tissues, including but not limited to cervix, skin, colon, breast, bladder, esophagus, liver, ovary, prostate, lung, pancreas, thyroid, kidney, stomach, testicle, uterus, spleen, tongue, brain, thymus, trachea and/or small intestine. In certain aspects, differential miRNA expression is initially determined by comparing miRNA expression between a normal tissue and cancer negative lymph node (LNneg), a normal tissue and a cancer positive lymph node (LNpos), a cancerous tissue and LNneg and/or LNpos, LNneg and LNpos. The methods of the invention are used to identify the presence or absence of non-lymphoid cells from other organs or tissues, and/or metastatic cancer cells present in lymph nodes. | 05-22-2014 |
Martina Ebenbeck, Hilchenbach DE
Patent application number | Description | Published |
---|---|---|
20090139350 | Device for Measuring the Strip Tension in a Metal Strip - The invention concerns a device ( | 06-04-2009 |
Martina Elsenheimer, Rhenine DE
Patent application number | Description | Published |
---|---|---|
20110076140 | HOUSING FOR THE NACELLE OF A WIND TURBINE - Disclosed is a housing for the nacelle of a wind turbine, comprising a support structure ( | 03-31-2011 |
Martina Fatho, Worrstadt DE
Patent application number | Description | Published |
---|---|---|
20090104186 | Melanoma-associated MHC class I associated oligopeptides and the uses thereof - The present invention relates to certain melanoma-associated oligopeptides that are recognized by CD8-positive cytotoxic T-lymphocytes (CTLs) as peptide antigen and which elicit a CTL-induced lysis and/or apoptosis of tumor cells. The present invention also relates to the use of these melanoma-associated oligopeptides in cancer therapy. | 04-23-2009 |
20100035267 | Detection of Individual T-Cell Reaction Patterns Against Tumor-Associated Antigens (TAA) in Tumor Patients as a Basis for the Individual Therapeutic Vaccination of Patients - The present invention relates to a method for identifying the preferential target antigens of antitumoural T-cells of a tumour patient, comprising: a) providing T-cells from the blood of at least one tumour patient, b) providing dendritic cell (DCs) and/or B-lymphocytes (BLCs) that are autologous for said tumour patient, wherein said DCs and BLCs were transfected beforehand with a selection of mRNAs encoding for T-cell-immunogenic tumour-associated antigens (TAA), and express these, c) contacting said T-cells with the DCs and/or BLCs, d) identifying of those T-cells that recognize antigens of the DCs and/or BLCs, and e) identifying of the preferential target antigens of antitumoural T-cells of the at least one tumour patient on the basis of the T-cells that recognize antigens of the DCs and/or BLCs. The method can furthermore comprise the expansion of the T-cells that recognize the antigens of the DCs and/or BLCs. The present invention furthermore relates to a method for producing an individualized tumour vaccine or individualized tumour therapeutic, as well as corresponding methods for treating a tumourous disease using the individualised tumour vaccine or individualised tumour therapeutic. | 02-11-2010 |
Martina Fischer, Munich DE
Patent application number | Description | Published |
---|---|---|
20100168392 | EXPRESSION OF FULL LENGTH IGG AND SECRETION INTO THE CULTURE MEDIUM OF PROKARYOTIC CELLS - A method for the production of an immunoglobulin or a functional fragment thereof in a prokaryotic host cell comprises transforming the host cell with (a) a first nucleic acid molecule comprising a nucleic acid sequence encoding a V | 07-01-2010 |
Martina Gattringer, Liebenau AT
Patent application number | Description | Published |
---|---|---|
20100203640 | Antigen Presenting Cells - The present invention relates to a method for inducing specific long-lasting robust immunological tolerance towards at least one polypeptide derived from at least one allergen by transplanting a hematopoietic (stem) cell which is produced to display the said at least one polypeptide derived from at least one allergen. | 08-12-2010 |
Martina Gottheis, Langenselbold DE
Patent application number | Description | Published |
---|---|---|
20110037021 | STORAGE-STABLE PRODUCT SYSTEMS FOR PREMIX FORMULATIONS - The present invention relates to storage-stable product systems having high latency and good mechanical stability, which are suitable, inter alia, for premix formulations. Furthermore, the present invention relates to a method for producing the formulations according to the invention and the use thereof. | 02-17-2011 |
20110078920 | SWEAT-ABSORBING SHOE SOLE INSERTS HAVING IMPROVED SWEAT ABSORPTION - A method of improving perspiration absorbency in a shoe or boot using particulate amorphous silica as an absorbent in insoles for shoes and/or boots, as well as a shoe insole containing an absorbent which contains particulate amorphous silica, and footware containing the insole. | 04-07-2011 |
Martina Hasenjaeger, Offenbach DE
Patent application number | Description | Published |
---|---|---|
20090035130 | SHAPE OF GAS PASSAGE IN AXIAL-FLOW GAS TURBINE ENGINE - An axial-flow gas turbine engine includes a plurality of inlet guide vanes (V) which are radially disposed in an annular gas passage defined between an inner peripheral wall (Ch) and an outer peripheral wall (Ct) of a turbine. The inner peripheral wall (Ch) of the gas passage includes inner peripheral concave portions (Cc | 02-05-2009 |
Martina Havelkova, Tromso NO
Patent application number | Description | Published |
---|---|---|
20130035296 | THERAPEUTIC PEPTIDES - The present invention provides a peptide, peptidomimetic or amino acid derivative having a net positive charge of at least +2 and incorporating a disubstituted β amino acid, each of the substituting groups in the β amino acid, which may be the same or different, comprises at least (7) non-hydrogen atoms, is lipophilic and has at least one cyclic group, one or more cyclic groups within a substituting group may be linked or fused to one or more cyclic groups within the other substituting group and where cyclic groups are fused in this way the combined total number of non-hydrogen atoms for the two substituting groups is at least (12), for use as a cytolytic therapeutic agent; as well as non therapeutic uses of these molecules and certain defined novel compounds from within this definition. | 02-07-2013 |
Martina Herrmann, Einbeck DE
Patent application number | Description | Published |
---|---|---|
20090220625 | SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACT - Described is a formulation having a skin irritation-reducing action consisting of or comprising: bisabolol and a composition or compound chosen from the group consisting of a) substance mixtures obtainable from an extraction of ginger, b) substance mixtures obtainable from a separation of a ginger extract which comprise a compound which is chosen from the group consisting of gingerols, shogaols, gingerdiols, dehydrogingerdiones, paradols and derivatives thereof and c) compounds obtainable from a separation of a ginger extract which are chosen from the group consisting of gingerols, shogaols, gingerdiols, dehydrogingerdiones, paradols and derivatives thereof and mixtures thereof, wherein the particular content of bisabolol and of the said composition or compound in the formulation is adjusted such that the skin irritation-reducing action of these contents is increased synergistically. | 09-03-2009 |
Martina Hurlebaus, Verden DE
Patent application number | Description | Published |
---|---|---|
20100028483 | SOLID EDIBLE PRODUCT FOR A PET - The present invention relates to a solid edible product for a pet having a moisture content of less than or equal to 10% comprising fat, a probiotic micro-organism and optionally a sweetener, a palatant and/or bulking material. The edible product may contain other ingredients. The invention also relates to a pet food product which comprises such a solid edible product as well as the solid edible product for improving or maintaining the health of a pet animal. | 02-04-2010 |
Martina Inhester, Bottrop DE
Patent application number | Description | Published |
---|---|---|
20080233378 | TRANSPARENT, ELECTRICALLY CONDUCTIVE LAYER, A PROCESS FOR PRODUCING THE LAYER AND ITS USE - Transparent, electrically conductive layer, a process for producing the layer and its use, wherein the layer is based on at least one compound of the formula 1 | 09-25-2008 |
20090309492 | Organic Light Emitting Component, and Production Method - The invention relates to an organic light emitting component, particularly an organic light emitting diode, in which an arrangement is formed that comprises a bottom electrode, a top electrode, and an organic layer region which is located between and is in electrical contact with the bottom electrode and the top electrode and contains at least one hole transport layer, at least one electron transport layer, and a light-emitting area. The bottom electrode is formed from a dispersion as a structured, binder-free, and optically transparent bottom electrode layer made of a bottom electrode material by means of a wet chemical application process, said bottom electrode material being an optically transparent, electrically conductive oxide. The bottom electrode layer has a sheet resistance of less than about 500 Ω/square and an optical refractive index of less than 1.8. | 12-17-2009 |
20110014437 | TRANSPARENT ELECTRICALLY CONDUCTIVE LAYER, A PROCESS FOR PRODUCING THE LAYER AND ITS USE - Transparent, electrically conductive layer, a process for producing the layer and its use, wherein the layer is based on at least one compound of the formula 1 | 01-20-2011 |
Martina Issleib, Hoisdorf DE
Patent application number | Description | Published |
---|---|---|
20100150854 | POLYETHYLENE GLYCOL ESTERS AND COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS - The invention relates to polyethylene glycol esters and blends of the polyethylene glycol esters with polyethylene glycol ethers, together with in particular cosmetic and/or dermatological preparations containing them, methods for the production thereof and use thereof. | 06-17-2010 |
20100284948 | O/W-EMULSIFIERS, O/W-EMULSIONS AND METHODS OF MANUFACTURE THEREOF - O/W-emulsifiers are described, comprising: | 11-11-2010 |
20120129937 | SOLUBILIZER FOR COSMETIC PREPARATIONS - The present invention relates to a mixture comprising (i) one or a plurality of 1,2-alkane diols with 5 through 8 carbon atoms and (ii) one or a plurality of ammonium-, sodium- or potassium-R | 05-24-2012 |
20130177510 | O/W-EMULSIFIERS, O/W-EMULSIONS AND METHODS OF MANUFACTURE THEREOF - O/W-emulsifiers are described, comprising: | 07-11-2013 |
Martina Joachimbauer, Haiming DE
Patent application number | Description | Published |
---|---|---|
20080293907 | Method for Preparing Ss-Ketocarbonyl-Functional Organo-Silicium Compounds - β-ketocarbonyl-functional organosilicon compounds are prepared by reacting amino organo-functional organosilicon compounds with a diketene in the presence of a compound which inhibits the reaction of amine groups with β-ketocarbonyl compounds. | 11-27-2008 |
20090156755 | Crosslinkable Silicone Coating Compositions - Crosslinkable silicone coating compositions are prepared from | 06-18-2009 |
20110021688 | Defoamer Formulations - (A) Siloxane-based antifoams and | 01-27-2011 |
Martina Kacirkova, Roztoky CZ
Patent application number | Description | Published |
---|---|---|
20100189786 | CRYSTALLINE TOLTERODINE TARTARATE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - A crystalline salt of 2-[(1R)-3-[bis(1-methylethyl)amino]- | 07-29-2010 |
Martina Kapuschinski, Wurzburg DE
Patent application number | Description | Published |
---|---|---|
20120040099 | SOL AND METHOD FOR PRODUCING A DELAFOSSITE MIXED OXIDE LAYER STRUCTURE ON A SUBSTRATE AND ALSO A SUBSTRATE COATED WITH A MIXED OXIDE - The present invention relates to a sedimentation-stable sol which, in addition to a copper(II) salt, also comprises at least one further metallic salt, an additive which is contained ensuring that the metallic salts contained in the sol remain dissolved or in dispersion. Furthermore, the sol is suitable in the method according to the invention for producing a metallic mixed oxide layer on a substrate, the metallic mixed oxide layer having a delafossite structure. Likewise, a substrate which has a metallic mixed oxide layer with a delafossite structure and also possibilities of use thereof are indicated according to the invention. | 02-16-2012 |
Martina Keller, Niefern DE
Patent application number | Description | Published |
---|---|---|
20100070336 | Providing Customer Relationship Management Application as Enterprise Services - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having customer relationship management functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 03-18-2010 |
Martina Kotthaus, Linz AT
Patent application number | Description | Published |
---|---|---|
20080306300 | Stepwise Execution of Exothermic Reactions with Participation of Carbocations - The invention relates to a method for carrying out reactions with participation of carbocations, whereby the initial most strongly exothermic phase of the reaction is carried out at high temperature (60 to 120° C.) and short residence time (1 to 30 seconds) in a microreactor and the subsequent less exothermic phases are carried out at optionally lower temperatures in two or more residence time units with longer residence times (1 to 30 seconds). | 12-11-2008 |
20100029990 | PROCESS FOR THE PRODUCTION OF COMPOUNDS VIA HAZARDOUS INTERMEDIATES IN A SERIES OF MICROREACTORS - Multi-step process for the preparation of compounds via hazardous intermediates comprising the steps of a) preparing in a microreactor a hazardous intermediate and b) optionally performing one or more reaction steps on the hazardous intermediate in one or more additional microreactors and c) further converting the hazardous intermediate with a suitable reaction agent in a subsequent microreactor until a stable end product is formed. | 02-04-2010 |
20100234630 | ALPHA-SUBSTITUTED A,B-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION A,B - This invention relates to novel alpha-substituted α,β-unsaturated E- or Z-aldehydes, or isomer mixture thereof, of the formula (I) in which R | 09-16-2010 |
20110301365 | ALPHA-SUBSTITUTED ALPHA, BETA-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION ALPHA, BETA - This invention relates to novel alpha-substituted α,β-unsaturated E- or Z-aldehydes, or isomer mixture thereof, of the formula | 12-08-2011 |
Martina Lahmann, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20100074938 | IMMOBILISED BIOLOGICAL ENTITIES - There is described inter alia a medical device having a surface which comprises a coating layer, said coating layer being a biocompatible composition comprising an entity capable of interacting with mammalian blood to prevent coagulation or thrombus formation, which entity is covalently attached to said surface through a link comprising a 1,2,3-triazole. | 03-25-2010 |
20150045508 | IMMOBILISED BIOLOGICAL ENTITIES - There is described inter alia a medical device having a surface which comprises a coating layer, said coating layer being a biocompatible composition comprising an entity capable of interacting with mammalian blood to prevent coagulation or thrombus formation, which entity is covalently attached to said surface through a link comprising a 1,2,3-triazole. | 02-12-2015 |
Martina Lahr, Weinheim DE
Patent application number | Description | Published |
---|---|---|
20100070324 | Architectural Design for Plan-Driven Procurement Application Software - Methods, systems, and apparatus, including computer program products, for implementing a software architecture design for a software application implementing plan-driven procurement. The application is structured as multiple process components interacting with each other through service interfaces, and multiple service operations, each being implemented for a respective process component. The process components include an Inbound Delivery Processing process component, a Site Logistics Processing process component, an Inventory Processing process component, a Purchase Request Processing process component, a Purchase Order Processing process component, a Purchasing Contract process component, a Supplier Invoice Processing process component, a Demand Forecast Processing process component, a Supply and Demand Matching process component, an External Procurement Trigger and Response process component, and a Logistics Execution Control process component. | 03-18-2010 |
20100070329 | Architectural Design for Opportunity Management Application Software - Methods, systems, and apparatus, including computer program products, for implementing a software architecture design for a software application implementing ad-hoc goods movement. The application is structured as multiple process components interacting with each other through service interfaces, and multiple service operations, each being implemented for a respective process component. The process components include, for example, a lead processing process component that handles the potential interests of a business partner and the interactions with the business partner over a certain timeframe; an opportunity processing process component that handles the development, processing, and monitoring of opportunities; a customer quote processing process component that handles the processing of quotes to customers offering the delivery of goods according to specific terms; and a sales order processing process component that handles the processing of customers' requests to seller for delivery of goods, on a specific date, for a specific quantity, and for a specific price. | 03-18-2010 |
20100070336 | Providing Customer Relationship Management Application as Enterprise Services - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having customer relationship management functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 03-18-2010 |
20100082497 | Providing Foundation Application as Enterprise Services - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having foundation layer functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 04-01-2010 |
20120047079 | PROVIDING FOUNDATION APPLICATION AS ENTERPRISE SERVICES - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having foundation layer functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 02-23-2012 |
Martina Marchetti-Deschmann, Vienna AT
Patent application number | Description | Published |
---|---|---|
20100126866 | METHODS OF DETERMINING POLYDISPERSITY AND/OR MOLECULAR WEIGHT DISTRIBUTION OF A POLYETHYLENE GLYCOL SAMPLE - Disclosed herein are methods of determining polydispersity (PDI) and molecular mass distribution (MMD) of reactive PEG samples using mass spectrometry. More specifically, a mass spectrometry method called GEMMA is used to determine PDI and MMD of PEG samples which provides more accurate measurements for high molecular weight PEG samples than prior known MALDI-TOF analysis. | 05-27-2010 |
20100155588 | RECOMBINANT VON WILLEBRAND FACTOR AS MOLECULAR WEIGHT MARKER FOR MASS SPECTROMETRY ANALYSES - Methods for determining molecular mass of at least 150 kDa of an analyte of interest using MALDI mass spectrometry in combination with a recombinant von Willebrand factor (rVWF) molecular weight marker are disclosed. More specifically, monomeric and multimeric rVWF are used for external and internal calibration of mass spectra applied for analytes having high molecular weights above 150 kDa. | 06-24-2010 |
20130043383 | Methods of Determining Polydispersity and/or Molecular Weight Distribution of a Polyethylene Glycol Sample - Disclosed herein are methods of determining polydispersity (PDI) and molecular mass distribution (MMD) of reactive PEG samples using mass spectrometry. More specifically, a mass spectrometry method called GEMMA is used to determine PDI and MMD of PEG samples which provides more accurate measurements for high molecular weight PEG samples than prior known MALDI-TOF analysis. | 02-21-2013 |
Martina Moellers, Drensteinfurt DE
Patent application number | Description | Published |
---|---|---|
20080220173 | Coating Agents Containing Adducts Having an Alkoxysilane Functionality - The invention relates to a coating material comprising (A) at least 50% by weight, based on the amount of nonvolatile substances in the coating material, of at least one compound (A1) containing at least one reactive group of the formula(I) | 09-11-2008 |
Martina Mühlanhoff, Hannover DE
Patent application number | Description | Published |
---|---|---|
20130012471 | MEANS AND METHODS FOR PRODUCING ARTIFICIAL CAPSULAR POLYSACCHARIDES OF NEISSERIA MENINGITIDIS - The invention provides for an in vitro method for producing capsular polysaccharides of | 01-10-2013 |
Martina Ochs, Lyon FR
Patent application number | Description | Published |
---|---|---|
20110287046 | MODIFIED STREPTOCOCCUS PNEUMONIA PNEUMOLYSIN (PLY) POLYPEPTIDES - This disclosure relates to modified | 11-24-2011 |
20140341942 | Modified Streptococcus Pneumonia Pneumolysin (PLY) Polypeptides - This disclosure relates to modified | 11-20-2014 |
Martina Ochs, Toronto CA
Patent application number | Description | Published |
---|---|---|
20100297133 | Immunogenic Polypeptides and Monoclonal Antibodies - Provided herein are compositions and methods for eliciting an immune response against | 11-25-2010 |
20130184200 | Immunogenic Polypeptides and Monoclonal Antibodies - Provided herein are compositions and methods for eliciting an immune response against | 07-18-2013 |
Martina Ochs-Onolemhemhen, Lyon FR
Patent application number | Description | Published |
---|---|---|
20110130300 | ASSAY FOR DIAGNOSING STREPTOCOCCUS PNEUMONIAE - Assays for detecting anti-streptococcal antibodies in biological samples using one or more streptococcal antigens are described herein. Various combinations of antigens may be used in the assays. For example, one or more of Ply, PhtD, PhtE, LytB and PcpA may be utilized. Additional streptococcal antigens may also be used. The assays may also be used in combination with assays that detect streptococcal nucleic acids. | 06-02-2011 |
20130034579 | IMMUNOGENIC COMPOSITIONS AND RELATED METHODS - This disclosure relates to adjuvants for use in immunogenic compositions comprising at least one antigen and an aluminum compound comprising hydroxyl groups that has been treated with phosphate, carboxylate, carbonate, sulfate diphosphonate or a mixture of two or more of these compounds and methods of using these compositions for preventing and treating diseases are also provided. | 02-07-2013 |
20130183350 | IMMUNOGENIC COMPOSITIONS - This disclosure relates to immunogenic compositions comprising an isolated immunogenic | 07-18-2013 |
20140349863 | Assay for Diagnosing Streptococcus Pneumoniae - Assays for detecting anti-streptococcal antibodies in biological samples using one or more streptococcal antigens are described herein. Various combinations of antigens may be used in the assays. For example, one or more of Ply, PhtD, PhtE, LytB and PcpA may be utilized. Additional streptococcal antigens may also be used. The assays may also be used in combination with assays that detect streptococcal nucleic acids. | 11-27-2014 |
Martina Ortelt, Duelmen DE
Patent application number | Description | Published |
---|---|---|
20110281117 | CURABLE COMPOSITION BASED ON EPOXY RESINS AND HETERO-POLY-CYCLIC POLYAMINES - The invention relates to curable compositions substantially comprising A) at least one epoxy resin, and B) at least one curing agent comprising a hetero-poly-cyclic ring system comprising at least two amino groups. | 11-17-2011 |
20120071577 | USE OF ISOCYANATES BASED ON RENEWABLE RAW MATERIALS - The invention relates to the use of 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-D-manitol (I), 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-D-glucitol (II), and/or 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-L-iditol (III). | 03-22-2012 |
20120077932 | COMPOSITIONS BASED ON DIISOCYANATES OBTAINED FROM RENEWABLE RAW MATERIALS - The invention relates to compositions based on 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-D-manitol (I), 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-D-glucitol (II), and/or 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-L-iditol (III), alone or in any mixtures. | 03-29-2012 |
20130253226 | PROCESS FOR PREPARING 3-AMINOMETHYL-3,5,5-TRIMETHYLCYCLOHEXYLAMINE - The invention relates to an improved process for preparing 3-aminomethyl-3,5,5-trimethylcyclohexylamine, referred to hereinafter as isophoronediamine or, in abbreviated form, IPDA, by: I. preparation of isophorone by catalyzed aldol condensations with acetone as reactant; II. reaction of isophorone with HCN to form isophoronenitrile (IPN, 3-cyano-3,5,5-trimethylcyclohexanone); III. catalytic hydrogenation and/or catalytic reductive amination (also referred to as aminative hydrogenation) of 3-cyano-3,5,5-trimethylcyclohexanone, hereinafter called isophoronenitrile or, in abbreviated form, IPN, to give the isophoronediamine. | 09-26-2013 |
20130303042 | PROCESS FOR THE PRODUCTION OF STORAGE-STABLE POLYURETHANE PREPREGS AND MOULDINGS PRODUCED THEREFROM FROM DISSOLVED POLYURETHANE COMPOSITION - The invention relates to a method for producing storage-stable polyurethane prepregs and molding bodies produced therefrom (composite components), which can be obtained by a method using a polyurethane composition in solution and by impregnation of fibre-reinforced materials such as of woven fabrics and laid scrim using reactive polyurethane compositions. | 11-14-2013 |
Martina Pantzar, Saro SE
Patent application number | Description | Published |
---|---|---|
20090074666 | Peptide vaccine for influenza virus - The invention relates to the method for evaluating the potential of a chemical entity, such as an antibody, to bind to a peptide epitope derived from the divalent sialoside binding site of hemagglutinin protein of influenza virus. The invention also provides peptide epitopes for use in the prevention and/or treatment of influenza or for the development of such treatment or vaccine against influenza. | 03-19-2009 |
Martina Papiorek, Hunfelden DE
Patent application number | Description | Published |
---|---|---|
20120123344 | PORT NEEDLE HAVING NEEDLE-PRICK PROTECTION DEVICE - The present invention relates to a port needle comprising a bearing for resting and fixing the port needle on the patient, a feed, and a needle. This problem is solved according to the invention by a port needle comprising a bearing ( | 05-17-2012 |
20130226103 | Port cannula for the puncturing of port catheters - A port cannula for puncturing implantable or implanted port catheters includes a cannula tube with a ground surface, which is formed from a ground cut inclined with respect to a center axis of the cannula tube by a ground-cut angle and from two facet cuts lying at an angle to each other, and of a cannula tip which is provided by the ground surface and which is oriented via a first bend in the direction of the center axis of the cannula tube. The ground cut and the facet cut are adapted to each other in such a way that, on the one hand, during puncturing, a bending of the cannula is least reduced and, on the other hand, the pain caused to the patient is kept within an acceptable range. | 08-29-2013 |
Martina Priebs, Freital DE
Patent application number | Description | Published |
---|---|---|
20100120762 | Triazine derivatives as inhibitors of phosphodiesterases - The invention relates to triazine derivatives of formula (I): | 05-13-2010 |
20100120763 | IMIDAZO[5,1-C][1,2,4]BENZOTRIAZINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES - The invention relates to imidazo[5,1-c][1,2,4]benzotriazine derivatives of formula I: | 05-13-2010 |
Martina Rehagen, Lohmar DE
Patent application number | Description | Published |
---|---|---|
20110046072 | SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE - The invention relates to a solid pharmaceutical preparation with delayed release of the active ingredients which is suitable in particular for use in animals. | 02-24-2011 |
Martina Richerzhagen, Ostercappeln DE
Patent application number | Description | Published |
---|---|---|
20100235048 | PROCESS AND DEVICE FOR DETERMINING A STEERING WHEEL ANGLE - A process is provided for determining a steering wheel angle (δ | 09-16-2010 |
Martina Ridlova, Bourg La Reine FR
Patent application number | Description | Published |
---|---|---|
20090266453 | METHOD FOR PURIFYING AN INPUT MIXTURE COMPRISING CARBON DIOXIDE (CO2) AND CARBON MONOXIDE (CO), TO ELIMINATE THE CARBON MONOXIDE CONTAINED IN SAID MIXTURE - The invention concerns in particular a method for purifying an input mixture comprising carbon dioxide (CO2) and carbon monoxide (CO), to eliminate the carbon monoxide contained in said mixture, which consists in contacting, at a temperature higher than room temperature, the input mixture with a purifying material comprising at least one metal oxide, so as to bring about the reduction of the purifying material by the input mixture, leading to oxidization of at least part of the CO of the input mixture into CO2. The invention also concerns a gaseous chilling method and installation integrating such a purifying operation. | 10-29-2009 |
Martina Rothley, Schwetzingen DE
Patent application number | Description | Published |
---|---|---|
20090171770 | INTEGRATED PURCHASING SYSTEM - A system for use in conjunction with an electronic purchasing guide may include definition of a purchasing objective, generation of an evaluation of the purchasing objective based on purchasing activity, identification of an employee performance indicator associated with the purchasing objective, and determination of an employee evaluation based on the employee performance indicator and the evaluation of the purchasing objective. | 07-02-2009 |
20090171809 | EFFICIENT PURCHASE ORDER CREATION - A system may include detection of a user selection of a purchasing-related document and, in response to the detection, automatic creation of a new purchase order based on the selected document. At least one data element of the new purchase order is identical to a data element of the selected document. | 07-02-2009 |
20100169228 | Integrated Negotiation Engine - A negotiation system and method for producing a set of transaction terms for a transaction between a purchaser and a supplier is presented. The negotiation system includes a negotiation tool adapted to receive and store supplier data and transaction data from one or more data sources via a communications network. The negotiation system further includes a simulation tool in communication with the negotiation tool to receive selected supplier data and selected transaction data from the supplier data and transaction data stored by the negotiation tool. The simulation tool is further adapted to generate, from the selected supplier data and selected transaction data, one or more simulations of the transaction, and to generate an interactive graphical representation of selected simulations of the one or more simulations in a graphical user interface for being displayed to a user | 07-01-2010 |
20120158555 | METHODS, APPARATUS, SYSTEMS AND COMPUTER READABLE MEDIUMS FOR USE IN ASSOCIATION WITH PURCHASING ACTIVITIES - According to some embodiments, a method comprises: receiving, by a processing system, data indicative of purchasing activities; displaying, by a processing system, a summary of at least a portion of the purchasing activities; receiving, by a processing system, a user request to simulate a change to the at least a portion of the purchasing activities; determining, by a processing system, at least one result of the simulated change to the at least a portion of the purchasing activities; displaying, by a processing system, the at least one result of the simulated change to the at least a portion of the purchasing activities; receiving, by a processing system, a user request to store data indicative of the at least one result; and storing, by a processing system, data indicative of the at least one result in association with the data indicative of the purchasing activities. | 06-21-2012 |
20120158601 | Defining And Monitoring Business Conduct - A code of business standards can be defined for an entity according to at least one predetermined abstract business standard. The defining can include assigning, in the code of business standards, at least one threshold level of activity relating to the predetermined abstract business standard. Activity instances in the at least one area of activity involving the entity can be monitored, for example by identifying an activity instance in violation of the defined code of business standards. The identifying can include detecting that the activity instance exceeds the at least one threshold level of activity. A solution for resolving the identified activity instance can be generated and promoted. Related methods, system, and computer program products are also described. | 06-21-2012 |
20130132233 | SUSTAINABILITY BASED SUPPLIER EVALUATION - Various embodiments of systems and methods for evaluating suppliers and performing green sourcing analysis based on customized sustainability metrics are described herein. The method in an integrated information management system involves configuring one or more criteria relating to a product as green sourcing metrics. The method further includes defining one or more constraints effecting interdependencies between the green sourcing metrics. In a further aspect, the method includes determining that the one or more constraints is fulfilled based on product data relating to one or more suppliers supplying the product and customizing the green sourcing metrics based on the one or more constraints that is fulfilled. In yet another aspect, the method involves performing green sourcing analysis for the one or more suppliers of the product based on the customized green sourcing metrics. Based on the green sourcing analysis, the one or more suppliers are evaluated and a sourcing recommendation is provided based on the evaluation. | 05-23-2013 |
20130144749 | SUPPLIER RATING AND REPORTING - Various embodiments of systems and methods for supplier rating and reporting are described herein. A first user interface is provided to a purchaser in response to a selection. The first user interface comprises one or more supplier analysis options. In response to selection of one or more of the options on the first user interface, a supplier rating analysis is generated and displayed using supplier evaluation data provided by a plurality of purchasers and stored in a data source. Based on a purchasing activity, a second user interface is provided to the purchaser. The second user interfaces comprises one or more input fields to capture the evaluation data from the purchaser. The input fields comprise supplier rating-level fields and supplier rating-criteria fields. The evaluation data is received after input by the purchaser. The evaluation data received from the purchaser is stored in the data source. | 06-06-2013 |
20130144865 | MANAGING ELECTRONIC PROCUREMENT TRANSACTIONS USING AN OPTIMIZED SEARCH TOOL - Various embodiments of systems and methods for retrieving open purchase orders using an optimized search tool are described herein. The method involves rendering a set of search parameters on a graphical UI of a computer. In an aspect, the method further includes receiving data relating to at least a first search parameter of the set of search parameters. Further, the method includes determining that data relating to at least a second search parameter of the set of search parameters is unavailable and determining the data relating to the at least second search parameter based on extrapolating the data relating to the at least first search parameter. In an aspect, the method involves performing a search based on the data relating to the at least first search parameter and the at least second search parameter. Based on the performed search, one or more open purchase orders are retrieved for further processing. | 06-06-2013 |
20130144880 | BUSINESS PARTNER GROUPING - A method and system, the method including defining business criteria for business entities, the business criteria including at least one business object attribute; defining at least one business partner group set, each of the at least one business partner group set being associated with at least one business object attribute selected from the business criteria; and modifying, by the computer, a record of a business entity by assigning the business entity to one or more of the defined business partner group sets. | 06-06-2013 |
20130166309 | BUSINESS PROCESS ADAPTATION TECHIQUES - Enhancement and adaptation of standard predefined business processes within a business software solution is performed by reusing business process elements, which are granular parts of the business processes. Connection of business entities to the reused business process elements ensures consistent business process adaptation. New business processes are defined in addition to the predefined business processes. | 06-27-2013 |
20130311215 | SUSTAINABILITY BASED DISTRIBUTION EVALUATION - A computer implemented method for analyzing distribution options of a product can include obtaining data relating to the distribution of the product to a customer from at least one supplier. The method can include configuring one or more criteria relating to the distribution of the product and weighting the criteria. At least one criteria can relate to sustainability of the distribution of the product. The method can include performing green distribution analysis on the distribution options of the product based on the weighted criteria using the obtained data and providing a set of distribution options based on the green distribution analysis. The distribution options can be provided with a green distribution score corresponding to the sustainability of the distribution option. | 11-21-2013 |
20130311216 | PRODUCT SUSTAINABILITY EVALUATION - A computer implemented method for analyzing sustainability of a product can include configuring one or more criteria relating to production and distribution of the product and weighting the criteria. At least one criteria can relate to the sustainability of the product. The method can include obtaining data relating to the production and the distribution of the product to a customer from at least one supplier. The method can include performing a green distribution analysis on the production and distribution of the product based on the weighted criteria using the obtained data. | 11-21-2013 |
20130346126 | BUSINESS PROCESS DEVELOPMENT - Various embodiments of systems and methods for composing business processes using customized business process elements are described herein. The method involves creating one or more partner-defined business process elements composed of a source business object node and a target business object node. Further, the method includes selecting a type of communication interface between the source business object node and the target business object node based on determining a relative location of the source business object node and the target business object node. In another aspect, the composed one or more business process elements are integrated to form a customized business process. In yet another aspect, the method includes switching business entities to the composed business process based on the partner-defined business process elements and persisting the developed business process in the repository. | 12-26-2013 |
20130346163 | AUTOMATICALLY MEASURING THE QUALITY OF PRODUCT MODULES - Various embodiments of systems and methods for measuring the quality of individual product modules over a lifecycle of a product are described herein. The method involves integrating error reports received from an internal incident management system and a customer incident management system. The method further includes associating the quality information in the error reports to a corresponding one or more product modules of a product and storing the association in a metadata repository. Using the quality information from the metadata repository, an automated evaluation of the quality of a product module is performed. In an aspect, the quality of a product module is represented as a quality indicator which is normalized with respect to a usage index of the product module. The generated quality indicator for the product module is associated with the product module and stored in the metadata repository with a time stamp for later access. | 12-26-2013 |
20140006067 | TRAVEL EXPENSE OPTIMIZER | 01-02-2014 |
20140173562 | Automatic Documentation Generator - The subject matter disclosed herein provides methods and apparatus, including computer program products, for generating a list of object descriptions based on an object's relevance for documentation. In one aspect there is provided a method that may include accepting a setting for a filter and a setting for a flag of an object. The filter setting may represent a type of information to be included in a list of object descriptions. The flag setting may represent a category of documentation relevance for the object that may be stored in a repository. The method may include comparing the filter setting with the flag setting of the object, extracting the description of the object from the repository based on the comparing of the flag setting with the filter setting, and generating the list of object descriptions that includes a description of the object. Related systems, apparatus, methods, and/or articles are also described. | 06-19-2014 |
20140278707 | Commodity Procurement System - A system and method include generating an indication regarding a need for a commodity from a manufacturing and resource planning system, estimating future prices of the commodity via a simulation tool as a function of current, historical, and simulated commodity prices, correlating the estimated future prices with a lead time to identify an optimal time to purchase the needed commodities, and generating a list of purchase orders via a computer system as a function of the correlation. | 09-18-2014 |
20150046355 | INTEGRATED TEMPORARY LABOR PROVISIONING AND MONITORING - Various embodiments herein include temporary labor provisioning and monitoring integrated within systems and processes. Some embodiments include receiving a temporary employee hiring request including data identifying requirements for a temporary employee. The received data is then stored and an approval process is initiated. Upon receipt of approval input, candidates may then be identified within a computing system of at least one other entity based on the requirements in the stored data. A selection of an identified candidate may then be received and a purchase order for the identified candidate may be generated. Subsequently, items may be added to the stored data representative of orientation activities, equipment and supplies to be provided to the identified candidate upon start of temporary employment, and human resources activities to be performed with regard to the identified candidate following a start of temporary employment. | 02-12-2015 |
Martina Schinke-Braun, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100280094 | COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS - The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2. | 11-04-2010 |
20120041052 | Compositions and Methods to Treat Muscular & Cardiovascular Disorders - The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2. | 02-16-2012 |
20120114744 | COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS - The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2. | 05-10-2012 |
Martina Schmid, Herrenberg DE
Patent application number | Description | Published |
---|---|---|
20100183709 | FORMULATION - The present invention relates to therapeutic formulations based on pumpkin products, in particular to encapsulated formulations for oral administration. A product of the invention comprises a hard gelatin capsule which encloses a unit dose of a formulation which comprises at least 50% by weight of one or more pumpkin product. | 07-22-2010 |
Martina Schmidt, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20110015266 | LYOPHILIZED NANOEMULSION - The present invention relates to a lyophilised nanoemulsion comprising a lipophilic phase and one or more sucrose fatty acid esters, to the nanoemulsion which can be prepared from the lyophilised nanoemulsion by redispersion, and to a process for the preparation of the lyophilised nanoemulsion. | 01-20-2011 |
Martina Schmitt, Winsen DE
Patent application number | Description | Published |
---|---|---|
20120238806 | IMPLANTATION SYSTEM WITH HANDLE AND CATHETER AND METHOD OF USE THEREOF - A system for deploying an implantable medical device into a body lumen is disclosed. The system comprises a catheter having functional zones for stability, protection, flexibility, trackability and pushability. The system further comprises a device for deploying an implantable medical device with the catheter. A method for deploying an implantable medical device into a body lumen using the system is also disclosed. | 09-20-2012 |
Martina Schmitt, Garstedt DE
Patent application number | Description | Published |
---|---|---|
20120209373 | Coated Stint - The invention relates to a stent, in particular intended for cardiovascular applications, provided with a bioresorbable polymer coating containing a restenosis-inhibiting agent, with said stent below its polymer coating having a metal surface which is smoothed by electropolishing and passivated and into which carbonium ions are implanted, with said polymer coating containing a (homo- or copolymer of hydroxycarboxylic acids which is terminally esterified. | 08-16-2012 |
Martina Schnatz, Bretten DE
Patent application number | Description | Published |
---|---|---|
20120240773 | FILTER ELEMENT FOR AN EXTRACTOR HOOD AND EXTRACTOR HOOD - A filter element for an extractor hood includes an odor filter having depressions provided in an entry side of the filter element and extending at least over half of a height of the filter element. A frame holds the odor filter at its edges and has a height which is smaller at least on one side of the frame than a height of the odor filter. | 09-27-2012 |
Martina Sinner-Lang, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20080254976 | ACTIVATED METATHESIS CATALYSTS - The present invention provides a process for preparing a supported catalyst (catalyst C) having a support (support S) selected from among oxides, phosphates, silicates, carbides, borides and nitrides of main group elements and elements of transition groups VI and II and mixtures of the abovementioned compounds and an active component (activator A) comprising one or more compounds containing one or more elements of transition groups V, VI and VII customary for the catalysis of metathesis reactions. | 10-16-2008 |
Martina Stattelmann, Meggen CH
Patent application number | Description | Published |
---|---|---|
20110099680 | Apparel - An aspect of the invention relates to a garment which comprises at least a first zone and a second zone. The first zone of the garment is arranged in the spine area and comprises a higher degree of air permeability than the second zone. The second zone of the garment is arranged below the breast area and in the area of the lumbar vertebrae and comprises a higher degree of moisture wicking than the first zone. | 05-05-2011 |
Martina Stattelmann, Herzogenaurach DE
Patent application number | Description | Published |
---|---|---|
20100218298 | Apparel - A garment which minimizes chafing includes a three-dimensional heat molded area and a seam connecting a front area of the garment with a back area of the garment. The seam may be curved and shaped to create a three-dimensionally shaped area. | 09-02-2010 |
Martina Unterhaslberger, Neuoetting DE
Patent application number | Description | Published |
---|---|---|
20120319032 | Biodegradable, Frost Proof Heat-Transfer Fluid, Use Thereof In Near-Surface Geothermal Installations, And A Concentrate For Preparing Same - Biodegradable, frost proof heat-transfer fluid, use thereof in near-surface geothermal installations, and a concentrate: subject matter of the present invention is the use of a triazole-free composition which as well as water comprises a) 9.2% to 49.5% by weight of at least one C | 12-20-2012 |
Martina Uttenreuther-Fischer, Biberach An Der Riss DE
Patent application number | Description | Published |
---|---|---|
20130012465 | BIBW 2992 FOR USE IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER - The present invention relates to a method of treating patients suffering from triple negative breast cancer comprising administration of an effective amount of the irreversible EGFR/HER1 and HER2 inhibitor BIBW 2992 (1) to a person in need of such treatment, optionally in combination with the administration of a further chemotherapeutic agent (2), in combination with radiotherapy, radio-immunotherapy and/or tumour resection by surgery. | 01-10-2013 |
Martina Von Freyburg, Heibronn DE
Patent application number | Description | Published |
---|---|---|
20130039946 | VACCINE COMPRISING AN ATTENUATED PESTIVIRUS - Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein E | 02-14-2013 |
Martina Von Freyburg, Ingelheim Am Rhein DE
Patent application number | Description | Published |
---|---|---|
20120201850 | INFECTIOUS BOVINE VIRAL DIARRHEA VIRUS - The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones. | 08-09-2012 |
Martina Wagner-Kuerten, Much DE
Patent application number | Description | Published |
---|---|---|
20110271798 | SCREW TENSIONING DEVICE - The screw tensioning device comprises a support tube ( | 11-10-2011 |
Martina Wernerova, Svidnik SK
Patent application number | Description | Published |
---|---|---|
20120283443 | Processes and Intermediates in the Preparation of Morphine Analogs via N-Demethylation of N-Oxides Using Cyclodehydration Reagents - A high-yielding method for the N-demethylation of oxycodone- and oxymorphone-N-oxides by the reaction of these compounds with cyclodehydration reagents has been performed. This method has been utilized to improve the synthesis of various morphine analogs, such as naltrexone, nalbuphone and naloxone. | 11-08-2012 |
Martina Wöbkemeier, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110000100 | LAUNDRY TREATMENT APPLIANCE COMPRISING A DRUM AND A SENSOR, AND METHOD FOR THE OPERATION THEREOF - A laundry treatment appliance having a drum; a motor to drive the drum; a control device, in which an acoustic reference signal is stored; an acoustic sensor to measure an acoustic signal; and a comparator to compare the acoustic signal recorded by the acoustic sensor with the acoustic reference signal stored in the control device; wherein each of the acoustic signal and the acoustic reference signal is a sonogram. | 01-06-2011 |
Martina Wöbkemeier, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110000100 | LAUNDRY TREATMENT APPLIANCE COMPRISING A DRUM AND A SENSOR, AND METHOD FOR THE OPERATION THEREOF - A laundry treatment appliance having a drum; a motor to drive the drum; a control device, in which an acoustic reference signal is stored; an acoustic sensor to measure an acoustic signal; and a comparator to compare the acoustic signal recorded by the acoustic sensor with the acoustic reference signal stored in the control device; wherein each of the acoustic signal and the acoustic reference signal is a sonogram. | 01-06-2011 |
Martina Zietsch, Gaiberg DE
Patent application number | Description | Published |
---|---|---|
20090317355 | ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION - The present invention relates to compositions for oral administration. The invention preferably comprises at least one abuse-resistant drug delivery composition for delivering a drug having potential for dose dumping in alcohol, related methods of preparing these dosage forms, and methods of treating a patient in need thereof comprising administering the inventive compositions to the patient. Most preferably, the dosage form includes verapamil. These formulations have reduced potential for abuse. In another formulation, preferably the abuse relevant drug is an opioid and the non-abuse relevant drug is acetaminophen or ibuprofen. More preferably, the opioid is hydrocodone, and the non-abuse relevant analgesic is acetaminophen. In certain preferred embodiments, the dosage forms are characterized by resistance to solvent extraction; tampering, crushing or grinding. Certain embodiments of the inventions provide dosage forms that provide an initial burst of release of drug followed by a prolonged period of controllable drug release. | 12-24-2009 |
20100172989 | ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION - The present invention relates to compositions for oral administration. The invention preferably comprises at least one abuse-resistant drug delivery composition for delivering a drug having potential for dose dumping in alcohol, related methods of preparing these dosage forms, and methods of treating a patient in need thereof comprising administering the inventive compositions to the patient. Most preferably, the dosage form includes verapamil. These formulations have reduced potential for abuse. In another formulation, preferably the abuse relevant drug is an opioid and the non-abuse relevant drug is acetaminophen or ibuprofen. More preferably, the opioid is hydrocodone, and the non-abuse relevant analgesic is acetaminophen. In certain preferred embodiments, the dosage forms are characterized by resistance to solvent extraction; tampering, crushing or grinding. Certain embodiments of the inventions provide dosage forms that provide an initial burst of release of drug followed by a prolonged period of controllable drug release. | 07-08-2010 |
20140120061 | ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION - The present invention relates to compositions for oral administration. The invention preferably comprises at least one abuse-resistant drug delivery composition for delivering a drug having potential for dose dumping in alcohol, related methods of preparing these dosage forms, and methods of treating a patient in need thereof comprising administering the inventive compositions to the patient. Most preferably, the dosage form includes verapamil. These formulations have reduced potential for abuse. In another formulation, preferably the abuse relevant drug is an opioid and the non-abuse relevant drug is acetaminophen or ibuprofen. More preferably, the opioid is hydrocodone, and the non-abuse relevant analgesic is acetaminophen. In certain preferred embodiments, the dosage forms are characterized by resistance to solvent extraction; tampering, crushing or grinding. Certain embodiments of the inventions provide dosage forms that provide an initial burst of release of drug followed by a prolonged period of controllable drug release. | 05-01-2014 |